Apimeds Pharmaceuticals US, Inc.

APUS Healthcare Drug Manufacturers Specialty & Generic

In the quarter to June 2026, EPS fell 352.7%, free cash flow fell 67.9% and total debt rose 2,468.3%, each against the same quarter a year earlier.

4.04 0.35 −7.97%
Market cap
$6.6M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23
Total current assets
13.98 0.01 0.42
Total non-current assets
150.20 — —
Total Assets
164.18 0.01 0.42
Total current liabilities
10.71 1.02 0.12
Total non-current liabilities
0.13 0.35 0.27
Total liabilities
10.84 1.37 0.39
Common Equity (Total)
153.27 (1.36) 0.03
Shareholders Equity (Total)
153.35 (1.36) 0.03
Total Debt
7.09 0.35 0.27

Show all line items

In millions of $ except per-share values · columns are period end dates